Richard Gelfond files Form 144 to sell IMAX shares
Richard Gelfond reports proposed sales of Common Stock under Form 144, totaling multiple transactions in March–April 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Richard Gelfond reports proposed sales of Common Stock under Form 144, totaling multiple transactions in March–April 2026. The notice lists individual proposed sale quantities and gross proceeds on specific dates, including 121,220 shares for $4,860,837.15 on 03/10/2026 and 135,046 shares for $5,106,872.53 on 04/10/2026.
Insights
Form 144 lists proposed affiliate sales with dated per-trade quantities and gross proceeds.
The filing records multiple proposed dispositions by Richard Gelfond in March–April 2026, each with a share count and a gross proceeds figure. These entries reflect planned sales under Rule 144 processes and include the method noted as cashless exercise / same-day sale.
Timing and completion status are not stated here; subsequent Form 4 or broker reports would show executed trades. Future filings will clarify actual sale settlements and any remaining holdings.
Key Figures
Key Terms
Form 144 regulatory
cashless exercise / same-day sale financial
acquired as compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does IMAX Form 144 filed by Richard Gelfond disclose?
What sale method is described in the Form 144 for these transactions?
Does Form 144 confirm the sales were completed?
Which dates show the largest proposed sales in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.